News | CT Angiography (CTA) | March 14, 2017

Study Affirms CT Angiography As Effective As Gold Standard for Predicting Heart Attacks

Radiology study finds CT angiography plus CT myocardial perfusion is equally effective as gold-standard invasive coronary angiography

CTA, CT angiography, predict heart attacks, Radiology study

March 14, 2017 — Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer a heart attack or other adverse cardiovascular event, according to a new study appearing online in the journal Radiology.

Cardiovascular disease is a leading cause of death worldwide. Bypass surgery or stent placement is often recommended in people with certain degrees of coronary arterial narrowing, or stenosis, but recent studies have shown that many of these patients do just as well with medical therapy. A key factor in treatment decisions is the hemodynamic significance of the lesion, meaning the degree to which the lesion is blocking blood from getting to areas of the heart.

“Previous studies show that a lesion is hemodynamically significant if there is a significant blood pressure drop corresponding to a big reduction in blood flow across the stenosis,” said study author João A.C. Lima, M.D., from Johns Hopkins Hospital and School of Medicine in Baltimore. “If plaque has those characteristics, the patient should be targeted for intervention, be it with a stent or downstream bypass surgery.”

A combination of invasive coronary angiography (ICA) and stress tests with single photon emission tomography (SPECT) myocardial imaging has been the gold standard for making these determinations, with ICA showing the blockages and SPECT the perfusion, or penetration of the blood into the tissue. However, ICA requires the use of a catheter that is threaded from a puncture point in the groin all the way up to the heart.

“Invasive angiography is generally safe, but it can cause vascular problems in a significant number of patients, most commonly at site of the puncture,” Lima said. “In rare cases, it can cause strokes or heart attacks. These risks are not trivial.”

The ICA/SPECT approach can also be expensive, as it often necessitates hospitalization for the patient.

“The traditional approach with invasive catheterization requires that patients go to the hospital, get a catheter inserted into their leg and go in for the nuclear SPECT study on a different day,” said study coauthor Marcus Chen, M.D., from the National Institutes of Health in Bethesda, Md. “Now with just one noninvasive test we can get two important but different pieces of information about the coronary arteries.”

The researchers set out to determine if combined CT angiography (CTA) and CT myocardial stress perfusion imaging (CTP) could demonstrate similar or superior ability to ICA/SPECT in predicting future adverse events.

They compared the invasive and noninvasive approaches in 379 patients who were referred for ICA from November 2009 to July 2011. The researchers looked at the ability of both techniques to predict whether or not a future major adverse cardiac event (MACE), such as a heart attack, revascularization, arrhythmia or hospitalization for chest pain or congestive heart failure would occur.

Fifty-one patients, or 13.5 percent, experienced one or more major adverse cardiac events, including 49 revascularizations, five myocardial infarctions, one cardiac death, nine hospitalizations for chest pain or congestive heart failure, and one arrhythmia.

Both techniques proved to have similarly high values for predicting MACE at two years after presentation and event-free survival. The two-year MACE-free rates for combined CT angiography and CT perfusion findings were 94 percent negative for coronary artery disease (CAD) versus 82 percent positive for CAD and were similar to combined ICA/SPECT findings (93 percent negative for CAD vs. 77 percent positive for CAD).

“The key finding of our study is that both techniques are equally effective in identifying which patients are going to have trouble down the road,” Lima said. “The noninvasive option should be a preferred or at least strongly considered option by cardiologists and radiologists managing these patients because it is safer and less expensive, and patients like it better.”

Obstacles remain before the noninvasive approach can achieve more widespread use, including the lack of a reimbursement code for stress CT perfusion. But the study indicates that the technique is relatively easy to incorporate into existing practices: Fifteen of the 16 centers in the trial had never done the procedure before, according to Chen, and all were all able to learn it effectively.

Watch the video "CT for Chest Pain Evaluation in The Emergency Department."

For more information: www.pubs.rsna.org/radiology

Related Content

New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent
News | Stents Peripheral| April 28, 2017
Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting, according to the...
Sponsored Content | Videos | Nuclear Imaging| April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
Vacancy Rates Rise for Radiographers in 2017 ASRT Survey
News | Business| April 27, 2017
The vacancy rate for radiographers increased to 4.2 percent in 2017, according to the latest American Society of...
Mercator MedSystems Announces First Enrollment in TANGO Trial for Below-the-Knee Vascular Disease
News | Peripheral Arterial Disease (PAD)| April 27, 2017
Mercator MedSystems Inc. announced the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to...
News | Venous Therapies| April 26, 2017
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the...
Twelve-Month Data Positive for Ranger Paclitaxel-Coated Balloon Catheter
News | Drug-Eluting Balloons| April 26, 2017
Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA Balloon Catheter at...
AATS Consensus Statement Helps Manage Treatment of Coronary Anomalies
News | Cardiac Diagnostics| April 26, 2017
The issues surrounding congenital coronary anomalies and their effect on sudden death are complex. Researchers are...
Body Weight Fluctuations Linked to More Deaths in People with Coronary Artery Disease
News | Cardiac Diagnostics| April 25, 2017
Repeated cycles of weight loss and gain may be linked to higher risk for stroke, heart attack and death in people with...
Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI)| April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons
Overlay Init